ARCT (STOCKS)
Arcturus Therapeutics Holdings Inc. Common Stock
$8.460000
+0.100000 (+1.20%)
Prev close: $8.360000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Joseph E. Payne
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $240.60M
- Employees
- 176
- P/E (TTM)
- -3.50
- P/B (TTM)
- 1.11
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $17.74M |
| Benefits Costs and Expenses | $37.54M |
| Costs And Expenses | $39.36M |
| Operating Expenses | $39.38M |
| Depreciation and Amortization | $643.00K |
| Research and Development | $20.37M |
| Other Operating Expenses | $18.38M |
| Operating Income/Loss | -$21.65M |
| Income/Loss From Continuing Operations After Tax | -$22.10M |
| Income/Loss From Continuing Operations Before Tax | -$19.80M |
| Net Income/Loss | -$22.10M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$22.10M |
| Net Income/Loss Available To Common Stockholders, Basic | -$22.10M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Assets | $44.42M |
| Current Assets | $36.61M |
| Prepaid Expenses | $807.00K |
| Other Current Assets | $35.80M |
| Noncurrent Assets | $7.81M |
| Fixed Assets | $2.02M |
| Other Non-current Assets | $5.80M |
| Liabilities | $38.07M |
| Current Liabilities | $14.61M |
| Accounts Payable | $4.12M |
| Wages | $1.02M |
| Other Current Liabilities | $9.48M |
| Noncurrent Liabilities | $23.45M |
| Equity | $6.35M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $6.35M |
| Liabilities And Equity | $44.42M |
| Net Cash Flow From Operating Activities | -$25.81M |
| Net Cash Flow From Operating Activities, Continuing | -$25.81M |
| Net Cash Flow From Investing Activities | $10.83M |
| Net Cash Flow From Investing Activities, Continuing | $10.83M |
| Net Cash Flow From Financing Activities | $15.40M |
| Net Cash Flow From Financing Activities, Continuing | $15.40M |
| Net Cash Flow | $420.00K |
| Net Cash Flow, Continuing | $420.00K |
| Comprehensive Income/Loss | -$22.09M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$22.09M |
| Other Comprehensive Income/Loss | -$22.09M |